Ask AI
Bill116th CongressFiled Mar 14, 2019Health
H.R. 1781

Payment Commission Data Act of 2019

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house (Oct 28, 2019)

Payment Commission Data Act of 2019

This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

What just happenedOct 29, 2019

Received in the Senate and Read twice and referred to the Committee on Finance.

Who’s behind it

Rep. Carter, Earl L. "Buddy" [R-GA-1](R-GA)Sponsor
29 cosponsors23 D6 R
Read on Congress.gov
29cosponsors3committees22actions6related bills7subjects
  1. Oct 29, 2019IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Finance Committee
  2. Oct 28, 2019FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Oct 28, 2019FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)

  4. Oct 28, 2019Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)

  5. Oct 28, 2019FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.

  6. Oct 28, 2019FloorH30000

    Considered under suspension of the rules. (consideration: CR H8526-8527)

  7. Oct 28, 2019FloorH30300

    Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.

  8. Oct 28, 2019CalendarsH12410

    Placed on the Union Calendar, Calendar No. 205.

  9. Oct 28, 2019DischargeH12300

    Committee on Ways and Means discharged.

    Ways and Means Committee
  10. Oct 28, 2019Committee5500

    Committee on Ways and Means discharged.

    Ways and Means Committee
  11. Oct 28, 2019CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.

    Energy and Commerce Committee
  12. Oct 28, 2019Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.

    Energy and Commerce Committee
  13. Apr 3, 2019Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  14. Apr 3, 2019Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  15. Mar 27, 2019Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  16. Mar 27, 2019Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  17. Mar 15, 2019Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  18. Mar 14, 2019Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  19. Mar 14, 2019IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  20. Mar 14, 2019IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  21. Mar 14, 2019IntroReferralIntro-H

    Introduced in House

  22. Mar 14, 2019IntroReferral1000

    Introduced in House

Passed HouseOct 28, 201953

Payment Commission Data Act of 2019

This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

Introduced in HouseMar 14, 2019

Payment Commission Data Act of 2019

This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

Payment Commission Data Act of 2019 — Informed